These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 21151209)
1. Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic. Seikrit C; Mühlfeld A; Groene HJ; Floege J Nat Rev Nephrol; 2011 Apr; 7(4):237-41. PubMed ID: 21151209 [TBL] [Abstract][Full Text] [Related]
2. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study. Evenepoel P; Sprangers B; Lerut E; Bammens B; Claes K; Kuypers D; Meijers B; Vanrenterghem Y Clin Transplant; 2012; 26(3):393-402. PubMed ID: 22007637 [TBL] [Abstract][Full Text] [Related]
3. Development of nephrolithiasis in a renal transplant patient during treatment with Cinacalcet. Seager CM; Srinivas TR; Flechner SM Ann Transplant; 2013 Jan; 18():31-5. PubMed ID: 23792498 [TBL] [Abstract][Full Text] [Related]
4. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism. Cruzado JM; Moreno P; Torregrosa JV; Taco O; Mast R; Gómez-Vaquero C; Polo C; Revuelta I; Francos J; Torras J; García-Barrasa A; Bestard O; Grinyó JM J Am Soc Nephrol; 2016 Aug; 27(8):2487-94. PubMed ID: 26647424 [TBL] [Abstract][Full Text] [Related]
5. Continuation of cinacalcet immediately after renal transplantation: a prospective cohort study. Aalten J; Wetzels JF; Hoitsma AJ Clin Nephrol; 2010 Dec; 74(6):433-9. PubMed ID: 21084046 [TBL] [Abstract][Full Text] [Related]
6. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Szwarc I; Argilés A; Garrigue V; Delmas S; Chong G; Deleuze S; Mourad G Transplantation; 2006 Sep; 82(5):675-80. PubMed ID: 16969292 [TBL] [Abstract][Full Text] [Related]
7. Management of hypercalcemia after renal transplantation. Torregrosa JV; Barros X Nefrologia; 2013 Nov; 33(6):751-7. PubMed ID: 24241361 [TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet. Apostolou T; Kollia K; Damianou L; Kaitsioti H; Kotsiev V; Dracopoulos S; Vougas V; Hadjiconstantinou V Transplant Proc; 2006 Dec; 38(10):3514-6. PubMed ID: 17175318 [TBL] [Abstract][Full Text] [Related]
9. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal. Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597 [TBL] [Abstract][Full Text] [Related]
10. Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation. Soliman AR; Maamoun HA; Soliman MA; Darwish H; Elbanna E Rom J Intern Med; 2016 Sep; 54(3):184-189. PubMed ID: 27658167 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study. Zavvos V; Fyssa L; Papasotiriou M; Papachristou E; Ntrinias T; Savvidaki E; Goumenos DS Exp Clin Transplant; 2018 Jun; 16(3):287-293. PubMed ID: 29108515 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic agents for disorders of bone and calcium metabolism. The calcimimetic cinacalcet HCl]. Nakanishi S; Fukagawa M Clin Calcium; 2007 Jan; 17(1):88-92. PubMed ID: 17211098 [TBL] [Abstract][Full Text] [Related]
13. The use of cinacalcet after pediatric renal transplantation: an international CERTAIN Registry analysis. Bernardor J; Schmitt CP; Oh J; Sellier-Leclerc AL; Büscher A; Dello Strologo L; Genc G; John U; Weitz M; Zirngibl M; Krupka K; Tönshoff B; Bacchetta J Pediatr Nephrol; 2020 Sep; 35(9):1707-1718. PubMed ID: 32367310 [TBL] [Abstract][Full Text] [Related]
14. Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet. Apostolou T; Damianou L; Kotsiev V; Drakopoulos S; Hadjiconstantinou V Clin Nephrol; 2006 May; 65(5):374-7. PubMed ID: 16724661 [TBL] [Abstract][Full Text] [Related]
15. Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism. Cho ME; Duan Z; Chamberlain CE; Reynolds JC; Ring MS; Mannon RB Transplant Proc; 2010 Nov; 42(9):3554-8. PubMed ID: 21094814 [TBL] [Abstract][Full Text] [Related]
16. Effects of cinacalcet in renal transplant patients with hyperparathyroidism. Courbebaisse M; Diet C; Timsit MO; Mamzer MF; Thervet E; Noel LH; Legendre C; Friedlander G; Martinez F; Prié D Am J Nephrol; 2012; 35(4):341-8. PubMed ID: 22473131 [TBL] [Abstract][Full Text] [Related]
17. Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism. Bergua C; Torregrosa JV; Cofán F; Oppenheimer F Transplant Proc; 2007 Sep; 39(7):2254-5. PubMed ID: 17889155 [TBL] [Abstract][Full Text] [Related]